| 1 |
Chi S, Li S, Xu Z, Yang G, Song Y, Liao Z, Yang C, Wu X. The involvement of DDX3X in compression-induced nucleus pulposus pyroptosis. Biochem Biophys Res Commun 2023;655:1-10. [PMID: 36907112 DOI: 10.1016/j.bbrc.2023.02.074] [Reference Citation Analysis]
|
| 2 |
Qi H, Wu F, Wang H. Function of TRPC1 in modulating hepatocellular carcinoma progression. Med Oncol 2023;40:97. [PMID: 36797544 DOI: 10.1007/s12032-023-01964-4] [Reference Citation Analysis]
|
| 3 |
Chen Z, Zhao Y, Tian Y, Cao R, Shang D. Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity. Biomolecules 2023;13. [PMID: 36830651 DOI: 10.3390/biom13020282] [Reference Citation Analysis]
|
| 4 |
Bai S, Wei Y, Liu R, Chen Y, Ma W, Wang M, Chen L, Luo Y, Du J. The role of transient receptor potential channels in metastasis. Biomed Pharmacother 2023;158:114074. [PMID: 36493698 DOI: 10.1016/j.biopha.2022.114074] [Reference Citation Analysis]
|
| 5 |
Song X, Hou L, Zhao Y, Guan Q, Li Z. Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer. Front Pharmacol 2022;13:1039499. [DOI: 10.3389/fphar.2022.1039499] [Reference Citation Analysis]
|
| 6 |
Yadalam PK, Anegundi RV, Ramadoss R, Joseph B, Veeramuthu A. Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain. Oral Oncol 2022;134:106094. [PMID: 36030559 DOI: 10.1016/j.oraloncology.2022.106094] [Reference Citation Analysis]
|
| 7 |
Chelaru NR, Chiosa A, Sorop A, Spiridon A, Cojocaru F, Domocos D, Cucu D, Popescu I, Dima SO. The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma. Int J Mol Sci 2022;23:9045. [PMID: 36012311 DOI: 10.3390/ijms23169045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Amantini C, Maggi F, Rossi de Vermandois JA, Gubbiotti M, Giannantoni A, Mearini E, Nabissi M, Tomassoni D, Santoni G, Morelli MB. The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer. Cancers (Basel) 2022;14. [PMID: 35804889 DOI: 10.3390/cancers14133118] [Reference Citation Analysis]
|
